BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SDT-M001 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of SDT-M001\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07096882-2722@assetmemo.bio
DTSTAMP:20261121T005454Z
DTSTART;VALUE=DATE:20270626
DTEND;VALUE=DATE:20270627
SUMMARY:SDT-M001: Phase 1 readout est. (NCT07096882)
DESCRIPTION:SDT-M001\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: SDTM00
 1 Injection as Adjuvant Therapy for NSCLC Patients After Radical Surgical 
 Resection\nEstimated primary completion: 26 June 2027. This is a ClinicalT
 rials.gov estimate\, not a confirmed readout date\, and it can move.\nDrug
  page: https://assetmemo.bio/drug/sdt-m001#upcoming-events\nRegistry recor
 d: https://clinicaltrials.gov/study/NCT07096882
URL:https://assetmemo.bio/drug/sdt-m001#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
